Changchun BCHT Biotechnology Co. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Changchun BCHT Biotechnology Co.

Why is Changchun BCHT Biotechnology Co. ?

Poor long term growth as Net Sales has grown by an annual rate of -17.01% and Operating profit at -178.63% over the last 5 years

With a fall in Net Sales of -53.5%, the company declared Very Negative results in Sep 25

The company has declared negative results for the last 3 consecutive quarters
NET SALES(Q) At CNY 189.55 MM has Fallen at -53.5%
OPERATING CASH FLOW(Y) Lowest at CNY 159.3 MM
ROCE(HY) Lowest at -4.18%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -20.84%, its profits have fallen by -96%
At the current price, the company has a high dividend yield of 1.3

Below par performance in long term as well as near term

Along with generating -20.84% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Changchun BCHT Biotechnology Co. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Changchun BCHT Biotechnology Co.

-29.66%

-1.43

27.98%

China Shanghai Composite

3.56%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-15.00%

EBIT Growth (5y)

-188.87%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.01

Sales to Capital Employed (avg)

0.29

Tax Ratio

23.10%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

8.70%

ROE (avg)

10.03%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.46

EV to EBIT

-18.02

EV to EBITDA

-27.01

EV to Capital Employed

1.45

EV to Sales

9.73

PEG Ratio

Dividend Yield

ROCE (Latest)

-8.03%

ROE (Latest)

-6.95%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

NET PROFIT(HY)

Higher at CNY -52.1 MM

NET SALES(Q)

At CNY 157.16 MM has Grown at 28.19%

OPERATING PROFIT(Q)

Highest at CNY 3.49 MM

OPERATING PROFIT MARGIN(Q)

Highest at 2.22 %

-21What is not working for the Company

NET PROFIT(9M)

At CNY -156.43 MM has Grown at -82.21%

NET SALES(9M)

At CNY 435.15 MM has Grown at -10.82%

RAW MATERIAL COST(Y)

Grown by 23.78% (YoY

DEBT-EQUITY RATIO (HY)

Highest at 4.95 %

INTEREST(Q)

Highest at CNY 1.85 MM

Here's what is working for Changchun BCHT Biotechnology Co.

Net Profit

Higher at CNY -52.1 MM

than preceding 12 month period ended Jun 2026

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CNY MM)

Net Sales

At CNY 157.16 MM has Grown at 28.19%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit

Highest at CNY 3.49 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Operating Profit Margin

Highest at 2.22 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Depreciation

Highest at CNY 48.53 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (CNY MM)

Depreciation

At CNY 48.53 MM has Grown at inf%

period on period (QoQ)

MOJO Watch

The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (CNY MM)

Here's what is not working for Changchun BCHT Biotechnology Co.

Interest

At CNY 1.85 MM has Grown at 34.38%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest

Highest at CNY 1.85 MM

in the last five periods and Increased by 34.38% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debt-Equity Ratio

Highest at 4.95 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost

Grown by 23.78% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales